Cargando…
ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the Wnt/β-catenin signaling pathway in vitro
BACKGROUND: ADAMTS12, a member of the ADAMTS family, is reported to be associated with the clinic outcome of colorectal cancer (CRC) patients. However, the functions and precise mechanism in CRC progression have yet to be fully understood. METHODS: By analyzing The Cancer Genome Atlas (TCGA) databas...
Autores principales: | Li, Chunxue, Luo, Xuelian, Huang, Bin, Wang, Xiangfeng, Deng, Yi, Zhong, Zhaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186627/ https://www.ncbi.nlm.nih.gov/pubmed/32355745 http://dx.doi.org/10.21037/atm.2020.02.154 |
Ejemplares similares
-
Wnt2 complements Wnt/β-catenin signaling in colorectal cancer
por: Jung, Youn-Sang, et al.
Publicado: (2015) -
Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer
por: Bian, Jia, et al.
Publicado: (2020) -
Long non‐coding RNA ADAMTS9‐AS1 suppresses colorectal cancer by inhibiting the Wnt/β‐catenin signalling pathway and is a potential diagnostic biomarker
por: Li, Ning, et al.
Publicado: (2020) -
KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer
por: Yao, Hanhui, et al.
Publicado: (2022) -
Role of Wnt/β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
por: Yuan, Shengli, et al.
Publicado: (2020)